Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
-
David Ray
Professor of Endocrinology and Co-Director Sir Jules Thorn Sleep and Circadian Neuroscience Institute
Latest publications
-
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology. Reply to Matveyenko A, Vella A [letter]
Journal article
Gandasi NR. and Rorsman P., (2024), Diabetologia
-
The value of neck adipose tissue as a predictor for metabolic risk in health and type 2 diabetes
Journal article
Cresswell E. et al, (2024), Biochemical Pharmacology
-
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity.
Journal article
Golubic R. et al, (2024), Diabetes Obes Metab
-
The value of neck adipose tissue as a predictor for metabolic risk in health and type 2 diabetes.
Journal article
Cresswell E. et al, (2024), Biochem Pharmacol, 223
Latest News
The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment
16 April 2024
The first participant has completed initial study activities and is now randomised to one of the trial’s arms.
Professor Rury Holman wins 2024 Banting Medal for Scientific Achievement
6 March 2024
The American Diabetes Association (ADA) has announced this year's National Scientific and Health Care Achievement Award recipients.
Race to cure type 1 diabetes gets a new boost
7 December 2023
RDM group awarded £2.55 million for diabetes research.
OCDEM Vacancies
Events
View previous and upcoming events in OCDEM.